EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Hepatocyte nuclear factor-6 is a novel transcriptional activator in cholangiocytes and is involved in the bile duct proliferative response to obstructive jaundice



Hepatocyte nuclear factor-6 is a novel transcriptional activator in cholangiocytes and is involved in the bile duct proliferative response to obstructive jaundice



Pediatrics 104(3 PART 3): 788, Sept




(PDF 0-2 workdays service: $29.90)

Accession: 035027880

Download citation: RISBibTeXText



Related references

Profile of hepatocyte apoptosis and bile lakes before and after bile duct decompression in severe obstructive jaundice patients. Hepatobiliary & Pancreatic Diseases International 9(5): 520-523, 2011

Are bile acids involved in the renal dysfunction of obstructive jaundice? An experimental study in bile duct ligated rats. Renal Failure 26(5): 507-516, 2004

Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. American Journal of Physiology 274(4 Pt 1): G767-G775, 1998

Bile duct endoprostheses with special regard to long time observations of patients with obstructive jaundice caused by bile duct stones. Zeitschrift fuer Gastroenterologie 29(SUPPL 2): 39-41, 1991

The transcriptional activator hepatocyte nuclear factor 6 regulates liver gene expression. Molecular and Cellular Biology 16(11): 6273-6284, 1996

Metabolic alterations in obstructive jaundice: effect of duration of jaundice and bile-duct decompression. Hpb Surgery 5(1): 35-48, 1991

Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 17(12): 2429-2432, 1990

Critical structural elements and multitarget protein interactions of the transcriptional activator AF-1 of hepatocyte nuclear factor 4. Journal of Biological Chemistry 273(45): 29950-7, 1998

Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes 51(5): 1409-1418, 2002

Obstructive jaundice from stone in the common bile duct in aplasia of the gallbladder; multiple and papillary cholelithiasis of the common bile duct. Zentralblatt für Chirurgie 75(24/A): 1721-1722, 1950

Do small cholangiocytes respond physiologically shortly after bile duct ligation and acquire phenotypes of large cholangiocytes?. Gastroenterology 112(4 SUPPL ): A1318, 1997

Alterations in the DNA binding activity of transcriptional factors activator protein-1, Sp1, and hepatocyte nuclear factor-1 in rat jejunum during starvation and refeeding. Journal of Gastroenterology and Hepatology 18(6): 705-711, 2003

Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats. Virchows Archiv 444(6): 554-560, 2004

Diagnosis of malignant obstructive jaundice by bile cytology: results improved by dilating the bile duct strictures. Gastrointestinal Endoscopy 40(2 Pt 1): 150-154, 1994

Sulfobromophthalein appearance-time in bile; its diagnostic value in incomplete obstructive jaundice and in nonicteric obstruction of the common bile duct. A.M.A. Archives of Surgery 66(4): 397-398, 1953